- Hebrew SeniorLife: “New training program facilitates home-based transcranial electrical stimulation Home-based treatment can be easier and more accessible for older adults” (July 17, 2024)
- Birnbach Communications: “Birnbach Communications Expands Team, Deepens Expertise with KOGS Communication” (July 10, 2024)
- Immunic Therapeutic: “Immunic Appoints Jason Tardio as Chief Operating Officer and President” (July 9, 2024)
- Hebrew SeniorLife: “A New Training Program Facilitates Home-Based Transcranial Electrical Stimulation Home-based treatment can be easier and more accessible for older adults” (July 2, 2024)
- Hebrew SeniorLife: “Frailty Is a Major Determinant of Postoperative Outcomes in Older Adults, Regardless of Surgery: Study shows significant impact of frailty on mortality and home time loss” (June 27, 2024)
- Hebrew SeniorLife: “Study Investigates Vascular Dysfunction as Mechanism Underlying Link Between Heart and Bone Health in Older Adults Data collected from the Framingham Heart Study” (June 21, 2024)
- Akston BioSciences: “Dr. Linda Rhodes Joins Akston Biosciences’ Board of Directors” (June 17, 2024)
- Hebrew SeniorLife: “Hebrew SeniorLife’s Jack Satter House To Receive up to $20 Million HUD Grant To Support Energy Efficiency and Climate Resilience Efforts: Democratic Whip Katherine Clark, HUD New England Regional Administrator Juana B. Matias, and other officials attend grant announcement” (June 11, 2024)
- Hebrew SeniorLife: “Study Finds Link Between BMI Trajectories and Fracture Risk in Late Adulthood Findings highlight the importance of stable BMI throughout adulthood” (May 30, 2024)
- Hebrew SeniorLife: “29 Nurses at Hebrew SeniorLife Nominated for Annual Salute to Nurses Nurses praised for outstanding work, compassion by co-workers, patients, families” (May 7, 2024)
- Hebrew SeniorLife: “Class of Alzheimer’s Drug Presents Unique Challenge for Patients With Cardiovascular Disease, Says JAMA Article: Authors advocate for additional research to improve decision-making before initiating lecanemab” (March 28, 2024)
- Akston Biosciences: “Akston Biosciences’ AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility” (March 11, 2024)
- Hebrew SeniorLife: “Study Finds Higher Risk for Fracture From Falls in Men Than in Women Previous falls should be integrated in FRAX to increase predictive accuracy of future falls” (March 8, 2024)
- Akston Biosciences: “Akston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility” (Feb. 26, 2024)
- Prota Therapeutics: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Birnbach Communications: “Birnbach Communications Issues Key Media, Business and Tech Predictions for 2024” (Jan. 9, 2024)
